Faron Pharmaceuticals Share Price (FARN)

61.00 +0.50 (+0.83%) delayed: 12:55PM GMT
Bid price 59.00 Open price 60.73
Ask price 63.00 Prev close 61.00
High price 64.75 Spread 6.35%
Low price 58.00 Volume 124,810

Register now for FREE live Faron Pharmaceuticals share prices, Faron Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Faron Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Faron Pharmaceuticals (FARN) and other London Stock Exchange equities.

Faron Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Faron Pharmaceuticals share price charts

Faron Pharmaceuticals Share Price Information

Name Faron Pharmaceuticals Epic FARN
Sector Pharmaceuticals & Biotechnology ISIN FI4000153309
Activites Faron Pharmaceuticals OY is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy. The Company's lead candidate Traumakine, to prevent vascular leakage and organ failures, is currently the only treatment for Acute Respiratory Distress Syndrome (ARDS) undergoing Phase III clinical trials and in 2017 received advice from US FDA to proceed directly to BLA submission following completion of EU and Japanese Phase III studies. There is currently no approved pharmaceutical treatment for ARDS. An additional European Phase II Traumakine trial is underway for the Rupture of Abdominal Aorta Aneurysm (RAAA). Faron's second candidate Clevegen is a ground breaking pre-clinical anti-Clever-1 antibody. Clevegen has the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development. This novel macrophage-directed immuno-oncology switch called Tumour Immunity Enabling Technology (TIET) may be used alone or in combination with other immune checkpoint molecules for the treatment of cancer patients. Index n/a

Faron Pharmaceuticals Key Numbers

Latest Share Price (p) 61.00 Net Gearing (%) 5.60
Market Capitalisation (£m) 18.77 Gross Gearing (%) 68.14
Shares in issue (m) 31.03 Debt Ratio 30.57
P/E Ratio -0.80 Debt-to-Equity Ratio 0.21
Total dividends per share (p) 0.00 Assets / Equity Ratio 3.14
Dividend Yield (%) 0.00 Price to book value 3.96
Dividend cover (x) 0.00 ROCE (%) -308.35
Earning per share (p) -76.00 EPS Growth (%) -94.87
52 week high / low 890.00 / 54.50 DPS Growth (%) n/a

Faron Pharmaceuticals Director Deals

Dec.Date Type Director Pos No. of Shares
21/06/2018 BUY Matti Manner NED 23,400
21/06/2018 BUY Yrjo Wichmann FD 5,200
21/06/2018 BUY Dr Markku Jalkanen CEO 36,000
21/06/2018 BUY Dr Juho Jalkanen NED 12,000
21/06/2018 BUY Dr Frank Armstrong CH 13,300

More Faron Pharmaceuticals Director Deals >>

Faron Pharmaceuticals Company News

11:20 14/12/2018

First patient dosed in phase I/II MATINS study

RNS Number : 5480K Faron Pharmaceuticals Oy 14 December 2018   Faron Pharmaceuticals Ltd ("Faron" or the "Company")   First patient dosed in phase I/II MATINS study of Clevegen   TURKU - FINLAND, 14 December 2018 - Faron Pharmaceuticals Ltd ( " Faron") (LON:...

16:26 11/12/2018

Holding(s) in Company

RNS Number : 1619K Faron Pharmaceuticals Oy 11 December 2018   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i...

10:27 05/12/2018

Faron Pharmaceuticals says trial shows ARDS treatment 'potentially very effective'

Faron Pharmaceuticals said Wednesday its treatment to prevent vascular leakage and organ failures showed a 'substantial reduction' in death rates for patients suffering from acute respiratory distress syndrome, underscoring the efficacy of the treatment. A clinical trial showed that acute...

More Faron Pharmaceuticals Company News >>

Register now for FREE Faron Pharmaceuticals company news

Faron Pharmaceuticals Share Price Discussions

No Faron Pharmaceuticals Share Price Discussions

Register now for FREE Faron Pharmaceuticals share price discussions